Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,070 USD | -0.12% |
|
+1.94% | +21.22% |
06-25 | Argus Adjusts Price Target on Regeneron Pharmaceuticals to $1,170 From $1,060, Buy Rating Maintained | MT |
06-20 | Declaration of Voting Results by Regeneron Pharmaceuticals, Inc | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.22% | 116B | |
+16.77% | 122B | |
+22.18% | 27.03B | |
-21.27% | 20.36B | |
-16.89% | 16.43B | |
-18.98% | 15.91B | |
-44.74% | 15.6B | |
+62.16% | 14.94B | |
+2.68% | 13.59B | |
+122.65% | 11.24B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing